|
Genticel completed recruitment for its phase Ib vaccine trial in women …
PipelineReview.com (press release) TOULOUSE, France I February 20, 2012 I Genticel announces today that it has completed the recruitment of all patients participating in its phase Ib clinical trial evaluating a lyophilized formulation of ProCervix, its candidate therapeutic HPV vaccine … |
View full post on hpv – Google News